STOCK TITAN

VYGR (NASDAQ: VYGR) holder files to sell 12,192 shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of VYGR common stock filed a notice of proposed sale under Rule 144 for 12,192 shares, to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $46,093.08. The issuer had 55,600,084 shares outstanding. The shares were acquired on 02/09/2026 through restricted stock vesting as compensation from the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing disclose for VYGR?

The Form 144 discloses a planned sale of 12,192 VYGR common shares under Rule 144. The shares were recently acquired through restricted stock vesting as compensation and are intended to be sold on the NASDAQ through Fidelity Brokerage Services LLC.

How many VYGR shares are proposed to be sold and at what value?

The filing shows a proposed sale of 12,192 VYGR common shares with an aggregate market value of $46,093.08. This reflects the total market value of the shares covered by this notice at the time the filing details were prepared.

When were the VYGR shares acquired and how were they obtained?

The 12,192 VYGR shares were acquired on 02/09/2026 through restricted stock vesting. The filing identifies the issuer as the source and classifies the vesting as compensation, indicating these shares stem from an equity award rather than an open-market purchase.

On which exchange will the VYGR shares be sold and through which broker?

The notice states that the VYGR common shares are intended to be sold on the NASDAQ. The designated broker for this planned Rule 144 transaction is Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island, as listed in the securities information table.

How many VYGR shares were outstanding when this Form 144 was filed?

The filing reports 55,600,084 VYGR common shares outstanding. This figure provides context for the size of the planned 12,192-share sale relative to the issuer’s total equity base but does not itself represent any new issuance or transaction.

What is the approximate date of sale for the VYGR shares in this Form 144?

The Form 144 lists an approximate date of sale of 02/10/2026 for the 12,192 VYGR common shares. This date reflects when the holder expects to begin selling the securities, subject to market conditions and Rule 144 requirements.
Voyager Therapeutics Inc

NASDAQ:VYGR

View VYGR Stock Overview

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

278.00M
46.22M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
LEXINGTON